EBITDA

A new deal pairs Inturai's AI sensing platform with a firm of elite special forces veterans, aiming to revolutionize intelligence for North American forces.

The record $70 million sale of AI.com to Crypto.com's CEO signals a new era for digital assets, where a domain name can define an entire industry.

With a promising spinal cord injury drug nearing late-stage trials, NervGen appoints interim leader Dr. Adam Rogers as permanent CEO to guide the breakthrough.

Emerging from stealth with Fortune 500 clients, Freehand's autonomous AI agents promise to end manual work in procurement and finance.

Bruker divisions unveil an open, AI-driven platform at SLAS2026, aiming to unify fragmented labs and enable 24/7 autonomous scientific discovery.

A new partnership integrates CME's premier FX venues into FlexTrade's platform, promising traders deeper liquidity and unprecedented market transparency.

ASUS unveils the ROG Strix Aiolos, a high-speed SSD enclosure targeting gamers and creators with 20Gbps transfers, advanced cooling, and exclusive software.

The Middle East healthcare giant posts record profits and a $163M dividend, fueled by aggressive international acquisitions and a major bet on AI technology.

Zoya Technologies unveils an autonomous AI clinic that operates without the cloud, promising to revolutionize healthcare in underserved regions worldwide.

As AI Day 2026 approaches, Algolia's CTO is set to unveil how the company is merging search and conversation to lead a user experience revolution.

Leading manufacturer GEVORKYAN is launching its first ESOP, a strategic move to retain key talent and drive growth in the competitive powder metallurgy market.

A new partnership aims to unlock a vital Swedish rare earth deposit, a project crucial for Europe's green goals but plagued by environmental hurdles.

Pulsar Helium's 100% success rate at its Topaz project hints at a vast new source of a rare isotope vital for national security and quantum computing.

Activist investor 3DIP alleges Toho Holdings created an “artificial emergency” to block engagement, igniting a battle over corporate governance in Japan.

The deal marks the final step in a major strategic overhaul for dsm-firmenich, which will now focus solely on its nutrition, health, and beauty businesses.

Median Technologies' eyonis® LCS gains landmark FDA clearance, promising to revolutionize early detection of the deadliest cancer with its AI-powered diagnostics.

Coinbase is back at the big game, swapping its viral QR code for a sing-along. Is this a savvy play for mainstream hearts or a high-risk brand gamble?

The UAE gas giant posts a 3% net income rise despite a 14% drop in crude prices, signaling major growth with a $3.6B investment surge.

With record sales and millions of parcels shipped, Doorzo's 2025 success reveals a blueprint for cross-border e-commerce and surging global demand.

Cantor Fitzgerald launches its 15th SPAC, raising $115M. With the market rebounding, will this bet on tech and healthcare pay off for investors?